Soligenix
SNGX
#10597
Rank
A$8.91 M
Marketcap
A$0.60
Share price
-5.45%
Change (1 day)
-78.34%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -A$19.38 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$13.23 Million a decrease over its 2023 earnings that were of -A$10.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.38 Million46.58%
2024 -A$13.23 Million22.96%
2023 -A$10.76 Million-45.74%
2022 -A$19.82 Million11.88%
2021 -A$17.72 Million-32.37%
2020 -A$26.19 Million83.18%
2019 -A$14.3 Million11.57%
2018 -A$12.82 Million19.29%
2017 -A$10.75 Million33%
2016 -A$8.08 Million-19.7%
2015 -A$10.06 Million5.16%
2014 -A$9.57 Million
2010 -A$10.8 Million26.12%
2009 -A$8.56 Million75.1%
2008 -A$4.89 Million-45.38%
2007 -A$8.95 Million-22.84%
2006 -A$11.6 Million66.15%
2005 -A$6.99 Million-16.65%
2004 -A$8.38 Million13.28%
2003 -A$7.4 Million-11.88%
2002 -A$8.39 Million-59.44%
2001 -A$20.69 Million378.18%
2000 -A$4.33 Million-38.53%
1999 -A$7.04 Million-18.43%
1998 -A$8.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.97 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.83 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-A$25.68 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$59.07 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.21 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-A$3.9 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA